Tech Company Financing Transactions
Cellectar Funding Round
Venture Investors, Advantage Capital Partners and private investors participated in a $13 million venture round for Cellectar. The round was recorded on 1/8/2008.
Transaction Overview
Company Name
Announced On
1/8/2008
Transaction Type
Venture Equity
Amount
$13,000,000
Round
Undisclosed
Investors
Venture Investors (Lead Investor) (John Neis)
Proceeds Purpose
Cellectar will use the money to continue operations and execute a Phase 1 clinical trial for its lead oncology product candidate, CLR1404, which is planned to start this summer. Cellectar recently opened a new manufacturing facility in Madison, WI which will make it possible to complete its clinical trials while remaining independent.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
100 Campus Dr. 207
Florham Park, NJ 07932
USA
Florham Park, NJ 07932
USA
Phone
Website
Email Address
Overview
Cellectar (NASDAQ: CLRB) is a radiopharmaceutical company designing and developing products to detect, treat, and monitor various human cancers.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Caruso
Chief Financial Officer
Dov Elefant
VP - Bus. Development
Jarrod Longcor
Browse more venture capital transactions:
Prev: 1/8/2008: STEP Labs venture capital transaction
Next: 1/8/2008: Pubmatic venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs